Full-Time

Clinical Scientist/Sr. Clinical Scientist

Early Oncology Development

Confirmed live in the last 24 hours

Scorpion Therapeutics

Scorpion Therapeutics

51-200 employees

Develops targeted small-molecule cancer drugs

Data & Analytics

Senior

San Francisco, CA, USA

Requirements
  • Advanced degree in science (PharmD, MD, DO, PA, NP, PhD, etc.)
  • 1+ years of experience in clinical research and/or drug development within the pharmaceutical industry
  • Prior drug development experience in oncology
  • Experience using Medidata EDC and data visualization programs (e.g., R-Shiny, SAS, SpotFire, Tableu, Excel Pivot Tables, etc.)
  • Experience in developing relationships with key investigators and KOLs
  • Knowledge of GCP/ICH, study design, statistics, and basic clinical operations
  • Experience writing, editing, and reviewing protocols, informed consent templates, study manuals, conference presentations, and journal publications
Responsibilities
  • Contribute to oversight of trials in start-up, conduct, and close-out for Phase I-III
  • Participate in critical site-facing activities (PSVs, SIVs, etc.)
  • Coordinate and conduct regular data/safety/efficacy reviews and identify trends across programs
  • Contribute to the cross functional trial team as the clinical sciences lead
  • Participate with the study team to prepare for and execute regulatory milestones
  • Contribute to the development of study documents for activities around study conduct
  • Work with statisticians/biometrics to develop required tables/listings/figures and contribute to the interpretation of efficacy and safety data
  • Present safety findings and study status to internal stakeholders
  • Coordinate presentations at IDMC meetings and other meetings
  • Participate in various initiatives and duties as required by the clinical development program

At Scorpion Therapeutics, our pursuit of advancing Precision Oncology 2.0, by developing targeted small-molecule drugs, makes us a leading edge in the field. With a focus on pioneering advancements in target discovery and medicinal chemistry, we are committed to overcoming the limitations of current cancer therapies. This creates a dynamic working environment, where employees are engaged in meaningful work that has the potential to significantly enhance patient outcomes in oncology.

Company Stage

Series A

Total Funding

$132.7M

Headquarters

Boston, Massachusetts

Founded

2020

Growth & Insights
Headcount

6 month growth

5%

1 year growth

10%

2 year growth

50%